Ribas J - Search Results

1

miR-21: an androgen receptor-regulated microRNA that promotes hormone-dependent and hormone-independent prostate cancer growth.

Ribas J, Ni X, Haffner M, Wentzel EA, Salmasi AH, Chowdhury WH, Kudrolli TA, Yegnasubramanian S, Luo J, Rodriguez R, Mendell JT, Lupold SE. Ribas J, et al. Cancer Res. 2009 Sep 15;69(18):7165-9. doi: 10.1158/0008-5472.CAN-09-1448. Epub 2009 Sep 8. Cancer Res. 2009. PMID: 19738047 Free PMC article.

2

Armoring CRAds with p21/Waf-1 shRNAs: the next generation of oncolytic adenoviruses.

Höti N, Chowdhury WH, Mustafa S, Ribas J, Castanares M, Johnson T, Liu M, Lupold SE, Rodriguez R. Höti N, et al. Among authors: ribas j. Cancer Gene Ther. 2010 Aug;17(8):585-97. doi: 10.1038/cgt.2010.15. Epub 2010 May 7. Cancer Gene Ther. 2010. PMID: 20448671 Free PMC article.

3

The transcriptional regulation of miR-21, its multiple transcripts, and their implication in prostate cancer.

Ribas J, Lupold SE. Ribas J, et al. Cell Cycle. 2010 Mar 1;9(5):923-9. doi: 10.4161/cc.9.5.10930. Epub 2010 Mar 11. Cell Cycle. 2010. PMID: 20160498 Free PMC article. Review.

4

A novel source for miR-21 expression through the alternative polyadenylation of VMP1 gene transcripts.

Ribas J, Ni X, Castanares M, Liu MM, Esopi D, Yegnasubramanian S, Rodriguez R, Mendell JT, Lupold SE. Ribas J, et al. Nucleic Acids Res. 2012 Aug;40(14):6821-33. doi: 10.1093/nar/gks308. Epub 2012 Apr 13. Nucleic Acids Res. 2012. PMID: 22505577 Free PMC article.

5

Investigation of miR-21, miR-141, and miR-221 expression levels in prostate adenocarcinoma for associated risk of recurrence after radical prostatectomy.

Zheng Q, Peskoe SB, Ribas J, Rafiqi F, Kudrolli T, Meeker AK, De Marzo AM, Platz EA, Lupold SE. Zheng Q, et al. Among authors: ribas j. Prostate. 2014 Dec;74(16):1655-62. doi: 10.1002/pros.22883. Epub 2014 Sep 22. Prostate. 2014. PMID: 25252191 Free PMC article.

6

Prostate-targeted radiosensitization via aptamer-shRNA chimeras in human tumor xenografts.

Ni X, Zhang Y, Ribas J, Chowdhury WH, Castanares M, Zhang Z, Laiho M, DeWeese TL, Lupold SE. Ni X, et al. Among authors: ribas j. J Clin Invest. 2011 Jun;121(6):2383-90. doi: 10.1172/JCI45109. Epub 2011 May 9. J Clin Invest. 2011. PMID: 21555850 Free PMC article.

7

A polymorphism of microRNA196a genome region was associated with decreased risk of glioma in Chinese population.

Dou T, Wu Q, Chen X, Ribas J, Ni X, Tang C, Huang F, Zhou L, Lu D. Dou T, et al. Among authors: ribas j. J Cancer Res Clin Oncol. 2010 Dec;136(12):1853-9. doi: 10.1007/s00432-010-0844-5. Epub 2010 Mar 14. J Cancer Res Clin Oncol. 2010. PMID: 20229273

8

SPP1 promoter polymorphisms and glioma risk in a Chinese Han population.

Chen J, Wu Q, Lu Y, Xu T, Huang Y, Ribas J, Ni X, Hu G, Huang F, Zhou L, Lu D. Chen J, et al. Among authors: ribas j. J Hum Genet. 2010 Jul;55(7):456-61. doi: 10.1038/jhg.2010.48. Epub 2010 May 27. J Hum Genet. 2010. PMID: 20505679

9

2-Phenylethynesulfonamide (PES) uncovers a necrotic process regulated by oxidative stress and p53.

Mattiolo P, Barbero-Farran A, Yuste VJ, Boix J, Ribas J. Mattiolo P, et al. Among authors: ribas j. Biochem Pharmacol. 2014 Oct 1;91(3):301-11. doi: 10.1016/j.bcp.2014.08.005. Epub 2014 Aug 16. Biochem Pharmacol. 2014. PMID: 25139326

10

7-Bromoindirubin-3'-oxime uncovers a serine protease-mediated paradigm of necrotic cell death.

Ribas J, Yuste VJ, Garrofé-Ochoa X, Meijer L, Esquerda JE, Boix J. Ribas J, et al. Biochem Pharmacol. 2008 Jul 1;76(1):39-52. doi: 10.1016/j.bcp.2008.03.023. Epub 2008 Apr 11. Biochem Pharmacol. 2008. PMID: 18485331 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

459 results

Search Page

Filters